TEJON RANCH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tejon Ranch Co., or the Company, (NYSE:TRC), a diversified real estate development and agribusiness company, today announced financial results for the three-months ended March 31, 2025. “Tejon Ranch is a one-of-a-kind asset, and I’m honored to take the helm of this incredible company,” said Matthew H. Walker, who assumed the duties of President and CEO of Tejon Ranch Co. on April 1, 2025. “Our first quarter results highlight the consistency of our long-t ...

Revenue of $665 million in the First Quarter, down 4% Year-over-YearPrivate Cloud Revenue was $250 million, down 7% Year-over-YearPublic Cloud Revenue was $416 million, down 2% Year-over-YearFirst Quarter 2025 Cash Flow From Operating Activities was $13 million; Cash Flow From Operating Activities was $143 million on a Trailing-Twelve-Month Basis SAN ANTONIO, May 08, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology, Inc. (Nasdaq: RXT), a leading end-to-end, hybrid cloud and AI solutions company, today announce ...

Third quarter fiscal 2025 net sales of $82.1 millionThird quarter fiscal 2025 gross margin increase of 200 basis points year-over-year to 42.1%Reported third quarter net loss of $5 million and improved adjusted EBITDA1 of $1.7 millionCompletion of the company’s brand pyramid and SKU rationalization initiative with the launch of its specialty coffee brand, Sum>One Coffee Roaster FORT WORTH, Texas, May 08, 2025 (GLOBE NEWSWIRE) -- Farmer Bros. Coffee Co. (NASDAQ: FARM) today reported its third quarter fiscal ...

Core Viewpoint - Okeanis Eco Tankers Corp. has declared options to repurchase three VLCC vessels, enhancing its capital structure and resilience against industry risks [1][4]. Financing Details - The company has secured a $130 million senior secured credit facility with a Greek bank to finance the repurchase of Nissos Nikouria and Nissos Anafi, expected to close in June and August 2025 respectively [2][3]. - The credit facility features an interest rate of Term SOFR plus 140 basis points, matures in seven years, and includes quarterly installments of $1.9 million and balloon payments of $76.8 million for both vessels [2]. Future Financing Plans - The company is actively seeking debt financing for the Nissos Kea, with expectations to announce details in Q2 2025, aiming for similar financial terms as the other two vessels [3][5]. Strategic Positioning - The financing will provide competitive terms, with debt maturing in 2032, aimed at improving future daily debt service breakeven costs [6]. - The company emphasizes its modern fleet built in quality shipyards in South Korea and Japan, positioning itself as a preferred platform in the crude tankers market [6].

ROGERS, Ark., May 08, 2025 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (“we,” “Car-Mart” or the “Company”), today announced that Jonathan Collins will assume the role of Chief Financial Officer (CFO) effective May 12, 2025. He will succeed Vickie Judy, who will transition to the position of Chief Accounting Officer (CAO). This transition is part of the Company’s continued focus on building a robust foundation to support long-term growth. “Since joining the Company in 2010, Vickie has played ...

Continues to Execute Strategic Initiatives to Accelerate Long-Term Profitable Growth Promotes Industry Veteran Tripp Wyckoff to Lead Adventure Entered into Agreement to Divest PIEPS Snow Safety Brand for €7.8 Million SALT LAKE CITY, May 08, 2025 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Summary vs. Same Ye ...

MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2025. First quarter results: Q1 2025Q1 2024Revenue$37.2 million$38.8 millionInstrument revenue$11.0 million$19.0 millionConsumable revenue$20.1 million$16.0 millionService and other revenue$6.0 million$3.8 million<td style="borde ...

Data cutoff date for Phase 2b NAVIGATE trial efficacy reached on April 30, 2025; top-line data readout expected in late June 2025Nature Microbiology publication highlights preclinical data and the potential of CD388 as a potent, universal antiviral for influenza prevention in healthy and high-risk populations regardless of immune statusConference call and webcast today at 5:00 PM Eastern Time SAN DIEGO, May 08, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology ...

Core Insights - Progyny, Inc. reported record revenue of $324.0 million for Q1 2025, reflecting a 16.5% growth compared to $278.1 million in Q1 2024, driven by an increase in clients and covered lives [4][5][14] - The company raised its full-year guidance due to a strong start to the year and ongoing demand in women's health and family building solutions [1][16] - Member engagement remains consistent with historical levels, indicating a strong desire for family building among members [3][12] Financial Performance - Revenue for Q1 2025 was $324.0 million, a 16.5% increase from $278.1 million in Q1 2024 [4][5] - Gross profit increased by 21% to $75.8 million, with a gross margin of 23.4%, up from 22.4% in the prior year [7][14] - Net income was $15.1 million, or $0.17 per diluted share, compared to $16.9 million, also $0.17 per diluted share, in Q1 2024 [8][34] - Adjusted EBITDA rose 15% to $57.8 million, with an adjusted EBITDA margin of 17.8%, slightly down from 18.1% in Q1 2024 [9][14] Cash Flow and Financial Position - Net cash provided by operating activities was $49.8 million in Q1 2025, compared to $25.7 million in Q1 2024, attributed to higher profitability [10] - As of March 31, 2025, the company had total working capital of approximately $330.6 million and no debt, with cash and cash equivalents totaling $256.1 million [11] Client Metrics - The company had 532 fertility and family building clients as of March 31, 2025, up from 451 clients a year earlier [12] - Fertility benefit services revenue was $206.4 million, a 22% increase from $169.8 million in Q1 2024, while pharmacy benefit services revenue increased by 9% to $117.6 million [14] Guidance and Outlook - For the full year 2025, revenue is projected to be between $1.185 billion and $1.235 billion, reflecting growth of 1.5% to 5.8% [20] - The second quarter of 2025 is expected to generate revenue between $310.0 million and $325.0 million, with net income projected between $11.5 million and $14.5 million [20]

Net Revenue of $71 million Gross Profit Margin of 51.8%, up 160 basis points from 50.2% in the fourth quarter of 2024 Net Cash provided by operations of $8.0 million and Free Cash Flow¹ of $5.5 million 11th consecutive quarter of positive Cash Flow from operations and 7th consecutive quarter of positive Free Cash Flow¹ Subsequent to quarter end, closed on acquisition of a dispensary in Ohio and signed definitive agreement to acquire a dispensary in New Jersey TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- TerrAs ...